O
ASLN

OrbiMed’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

OrbiMed’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-48,530
Closed -$1.75M – 153
2022
Q1 		$1.75M Sell
48,530
-720
-1% -$26.8K 0.03% 134
2021
Q4 		$2.21M Hold
49,250
– – 0.03% 148
2021
Q3 		$3.51M Sell
49,250
-13,750
-22% -$1.56M 0.04% 160
2021
Q2 		$8.32M Hold
63,000
– – 0.08% 133
2021
Q1 		$8.44M Buy
+63,000
New +$7.98M 0.08% 125

Other funds holding ASLN

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $29.7B AUM 13.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SCM
Sio Capital Management New York $694M AUM 79.73% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return